Adaptive Biotechnologies Cash from Operations (TTM) Analysis

Adaptive Biotechnologies Corp (ADPT)

3.51 -0.06 (-1.68%) USD | NASDAQ | May 10, 16:00

3.51 0.00 (0.00%) After-Hours: 18:22

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	-135.52M
December 31, 2023	-156.32M
September 30, 2023	-159.41M
June 30, 2023	-155.14M
March 31, 2023	-178.64M
December 31, 2022	-183.94M
September 30, 2022	-207.75M
June 30, 2022	-208.79M
March 31, 2022	-198.94M
December 31, 2021	-192.73M
September 30, 2021	-178.74M

Date	Value
June 30, 2021	-182.46M
March 31, 2021	-176.32M
December 31, 2020	-149.68M
September 30, 2020	-136.63M
June 30, 2020	-119.61M
March 31, 2020	-104.50M
December 31, 2019	205.40M
September 30, 2019	226.78M
June 30, 2019	245.24M
March 31, 2019	252.14M
December 31, 2018	-32.26M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-208.79M

Minimum

Jun 2022

245.24M

Maximum

Jun 2019

-107.39M

Average

-157.87M

Median

Cash from Operations (TTM) Benchmarks